Cdc42-related Autoinflammatory Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-03-03
Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations [Phase 2]
Phase 2 trial update on MAS825 for monogenic IL-18–driven autoinflammatory diseases, including NLRC4-GOF, XIAP deficiency, Autoinflammation …